Skip to content

The Efficacy Observation of rTMS in the Treatment of Children with ASD Complicated with Sleep Disorders

The Efficacy Observation of rTMS in the Treatment of Children with ASD Complicated with Sleep Disorders

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114357
Enrollment
Unknown
Registered
2025-12-10
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Experimental group:Combined rTMS and rehabilitation therapy
Control group:Sham control and rehabilitation therapy

Sponsors

Foshan Maternity & Child Healthcare Hospital,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for ASD specified in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), as well as the diagnostic criteria for sleep disorders outlined in the International Classification of Sleep Disorders, 3rd Edition (ICSD-3). 2–6 years of age; 2.Have not taken antipsychotic drugs, melatonin, sedative-hypnotic agents, or other similar medications recently. 3.Have no history of relevant systematic rehabilitation training before enrollment. 4.The guardians have provided written informed consent for the children's participation in this study.

Exclusion criteria

Exclusion criteria: 1.Complicated with other mental illnesses, severe neurological diseases, congenital structural abnormalities, or other relevant disorders. 2.Complicated with genetic metabolic disorders. 3.Complicated with contraindications to rTMS, such as epilepsy, organic brain lesions, cochlear implants, severe cardiovascular diseases, etc. 4.Those who failed to cooperate with treatment during the study or withdrew midway.

Design outcomes

Primary

MeasureTime frame
Assessment of sleep disorders.;

Secondary

MeasureTime frame
Efficacy with ASD.;Assessment of emotional and behavioral symptoms.;

Countries

China

Contacts

Public ContactSaijun Huang

Foshan Maternity & Child Healthcare Hospital,

tufanqie@163.com+86 757 82969788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026